reviewTop 1% cited
Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives
European Journal of Medicinal Chemistry · 2017 · Vol. 142 · pp. 8–31
Tatjana Lazarević(University of Kragujevac)Ana Rilak Simović✉(University of Kragujevac)Živadin D. Bugarčić✉(University of Kragujevac)
Metal complexes synthesis and propertiesFerrocene Chemistry and ApplicationsSynthesis of Tetrazole DerivativesChemistryProdrugCytotoxicityCombinatorial chemistryCisplatinRutheniumPharmacologyNanotechnologyPalladiumBioinorganic chemistry
MeSH terms
AnimalsAntineoplastic AgentsGoldHumansNeoplasmsPalladiumPlatinumRutheniumDrug DiscoveryCoordination Complexes
Funding
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja
Citations
413
FWCI
18.84
field-weighted impact
References
148
Percentile
100%
vs. same field & year
Citations per year
References
Cellular processing of platinum anticancer drugs
Nature Reviews Drug Discovery · 2005 · 3,720 citations
Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation
Biochemistry · 1985 · 1,009 citations
Metal-based antitumour drugs in the post genomic era
Dalton Transactions · 2006 · 760 citations
On the medicinal chemistry of gold complexes as anticancer drugs
Coordination Chemistry Reviews · 2009 · 808 citations
In Vitro and in Vivo Evaluation of Ruthenium(II)−Arene PTA Complexes
Journal of Medicinal Chemistry · 2005 · 769 citations
Challenges and Opportunities in the Development of Organometallic Anticancer Drugs
Organometallics · 2012 · 551 citations
The status of platinum anticancer drugs in the clinic and in clinical trials
Dalton Transactions · 2010 · 1,602 citations
Metal based drugs: from serendipity to design
Dalton Transactions · 2007 · 404 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.